BioCentury
ARTICLE | Financial News

Mologen completes rights offering

July 16, 2012 7:00 AM UTC

Mologen AG (Xetra:MGN), Berlin, Germany Business: Cancer, Infectious, Gene/Cell therapy Date completed: 7/10/12 Type: Rights offering Raised: €22 million ($27.1 million) Shares: 2.6 million Price: €8....